Evidence map›Paper›PMID 29403954›Full record

ArticleJournal of pharmaceutical analysis2015

Baishakhi Dey, Prakash Katakam, Fathi H Assaleh, Babu Rao Chandu, Shanta Kumari Adiki, Analava Mitra

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of pharmaceutical analysis, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Portable and automated analyzer for rapid and high precisionJournal of pharmaceutical analysis · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Baishakhi DeySchool of Medical Science and Technology, IIT Kharagpur, Kharagpur 721302, India.
Prakash KatakamFaculty of Pharmacy, University of Zawia, Az Zawiyah, Libya.
Fathi H AssalehFaculty of Pharmacy, University of Zawia, Az Zawiyah, Libya.
Babu Rao ChanduFaculty of Pharmacy, University of Zawia, Az Zawiyah, Libya.
Shanta Kumari AdikiDepartment of Pharmaceutical Analysis, Nirmala College of Pharmacy, Guntur, India.
Analava MitraSchool of Medical Science and Technology, IIT Kharagpur, Kharagpur 721302, India.
Al Zawiya University · LYIndian Institute of Technology Kharagpur · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ciprofloxacin, commonly used in India as an anti-microbial for prolonged use in chronic and non-specific indications, may affect the bioavailability of the drug. The drug prescribed is commonly taken with multivitamins, calcium and milk. A simple and reliable analytical methodology obtaining a correlation with

Indexed as

Analytical methodologyBioavailabilityBio-waiverCiprofloxacinDissolution study

Identifiers

PMID29403954
PMCPMC5762247
OpenAlexW2093547370

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.